GSK and the University of Oxford have launched the GSK-Oxford Cancer Immuno-Prevention Programme, a new research initiative focused on cancer preve ...
While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback